🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 14 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/12/2014 | 33,40 | 34,83 | 33,40 | 34,45 | +5,04% | 4,28% | 678.550 |
| 01/12/2014 | 33,51 | 33,71 | 32,71 | 32,79 | -2,38% | 3,00% | 424.795 |
| 28/11/2014 | 33,44 | 34,22 | 33,44 | 33,59 | +0,28% | 2,31% | 223.138 |
| 26/11/2014 | 33,58 | 33,99 | 33,31 | 33,50 | -0,54% | 2,01% | 352.820 |
| 25/11/2014 | 33,74 | 34,17 | 33,44 | 33,68 | -0,17% | 2,14% | 329.737 |
| 24/11/2014 | 33,19 | 33,97 | 33,08 | 33,74 | +1,94% | 2,67% | 387.445 |
| 21/11/2014 | 33,96 | 34,00 | 32,82 | 33,09 | -0,86% | 3,47% | 326.050 |
| 20/11/2014 | 33,42 | 33,88 | 32,65 | 33,38 | -0,72% | 3,68% | 571.790 |
| 19/11/2014 | 34,05 | 34,35 | 33,08 | 33,62 | -1,26% | 3,74% | 499.495 |
| 18/11/2014 | 35,57 | 36,46 | 33,57 | 34,05 | -4,14% | 8,10% | 763.669 |
| 17/11/2014 | 36,06 | 36,26 | 35,29 | 35,53 | -1,45% | 2,68% | 474.969 |
| 14/11/2014 | 36,18 | 36,33 | 35,49 | 36,05 | -0,29% | 2,33% | 452.046 |
| 13/11/2014 | 36,20 | 36,48 | 35,48 | 36,16 | +0,45% | 2,76% | 435.215 |
| 12/11/2014 | 35,08 | 36,13 | 34,94 | 36,00 | +1,41% | 3,38% | 341.920 |
| 11/11/2014 | 34,80 | 36,34 | 34,69 | 35,50 | +2,19% | 4,77% | 690.252 |
| 10/11/2014 | 33,79 | 34,77 | 33,18 | 34,73 | +3,23% | 4,71% | 512.319 |
| 07/11/2014 | 34,15 | 34,19 | 33,16 | 33,65 | -1,77% | 3,01% | 621.002 |
| 06/11/2014 | 34,49 | 34,99 | 33,84 | 34,25 | -0,69% | 3,35% | 560.890 |
| 05/11/2014 | 35,36 | 35,40 | 34,08 | 34,49 | -1,74% | 3,74% | 505.426 |
| 04/11/2014 | 34,97 | 35,65 | 34,80 | 35,10 | -0,39% | 2,43% | 622.766 |
| 03/11/2014 | 34,44 | 35,33 | 34,07 | 35,24 | +2,21% | 3,68% | 639.437 |
| 31/10/2014 | 34,69 | 35,76 | 34,19 | 34,48 | +1,66% | 4,53% | 577.080 |
| 30/10/2014 | 33,16 | 34,01 | 32,79 | 33,92 | +1,95% | 3,67% | 356.988 |
| 29/10/2014 | 32,75 | 33,42 | 31,58 | 33,27 | +2,78% | 5,60% | 815.606 |
| 28/10/2014 | 34,17 | 34,54 | 31,67 | 32,37 | -4,31% | 8,40% | 816.087 |
| 27/10/2014 | 34,01 | 34,47 | 32,29 | 33,83 | +0,48% | 6,40% | 892.871 |
| 24/10/2014 | 33,91 | 33,91 | 32,96 | 33,67 | -0,30% | 2,78% | 651.620 |
| 23/10/2014 | 32,31 | 34,20 | 32,25 | 33,77 | +6,83% | 6,04% | 795.890 |
| 22/10/2014 | 31,59 | 32,04 | 31,03 | 31,61 | +0,04% | 3,20% | 414.376 |
| 21/10/2014 | 31,50 | 32,12 | 31,02 | 31,60 | +0,82% | 3,49% | 385.522 |